13:39 EDT Can-Fite BioPharma (CANF) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CANF:
- Can-Fite Projects $685M Revenue from Partnerships
- Can-Fite BioPharma announces completion of analysis of current partnerships
- Can-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
- Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
- Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson